BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 2:46:00 PM | Browse: 1236 | Download: 1223
 |
Received |
|
2013-10-16 11:15 |
|
Peer-Review Started |
|
2013-10-16 16:14 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-11-14 16:16 |
|
Revised |
|
2013-11-15 04:41 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-01-02 10:56 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-01-02 12:02 |
|
Articles in Press |
|
2014-05-23 12:01 |
|
Edit the Manuscript by Language Editor |
|
2014-01-06 20:47 |
|
Typeset the Manuscript |
|
2014-05-28 09:24 |
|
Publish the Manuscript Online |
|
2014-06-21 13:56 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ezequiel Ridruejo |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ezequiel Ridruejo, MD, Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno “CEMIC”, Ciudad Autónoma de Buenos Aires, Avda, Las Heras 2939, C1425ASG Buenos Aires, Argentina. eridruejo@gmail.com |
| Key Words |
Hepatitis B; Clinical practice; Entecavir; Tenofovir; Real life |
| Core Tip |
Patients treated with entecavir or tenofovir in routine clinical practice at referral centres, with good clinical follow-up and adherence to international guidelines, can achieve high treatment response rates with a very low rate of adverse events. |
| Publish Date |
2014-06-21 13:56 |
| Citation |
Ridruejo E. Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir. World J Gastroenterol 2014; 20(23): 7169-7180 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i23/7169.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i23.7169 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
